非特殊型浸润性导管癌,IDC-NOS
1)IDC-NOS非特殊型浸润性导管癌
1.MethodsWe analyzed Fez1/Lzts1 protein expression in IMPC and invasive ductal carcinoma,no specific type(IDC-NOS) by IHC.【方法】采用免疫组织化学LSAB法检测100例IMPC中Fez1/Lzts1蛋白的表达,选取100例非特殊型浸润性导管癌(IDC-NOS)作为对照,比较Fez1/Lzts1蛋白在不同病理学类型中表达的差异,分析IMPC中Fez1/Lzts1蛋白的表达与淋巴结转移等相关病理学特征的关系;运用重亚硫酸盐处理基因组DNA-PCR扩增。
2)Non-special type invasive carcinoma of breast乳腺浸润性非特殊型癌
3)nonspecific invasive breast carcinoma浸润性非特殊癌
1.Background and Objective: To investigate the factors related with axillary Lymph node metastases fromnonspecific invasive breast carcinoma and to provide scientific basis for deciding conditions of breast cancer patients and giving auxiliary treatments after radical mastectomy.目的:探讨乳腺浸润性非特殊癌腋淋巴结转移的相关因素。
英文短句/例句
1.Study on the Multiple Factors of Axillary Lymph Node Metastases in Patients with Nonspecific Invasive Breast Carcinoma;乳腺浸润性非特殊癌腋淋巴结转移多因素分析
2.Differential analysis of two-dimensional gel electrophoresis profile of human non-muscle-invasive bladder cancer and invasive bladder cancer tissue非肌层浸润性和肌层浸润性膀胱癌的双向电泳图谱的差异分析
3.Greenlight photoselective vaporization (GPV) in the treatment of non muscle-invasive bladder cancer绿激光治疗非肌层浸润性膀胱癌(附56例报告)
4.lobular infiltrating carcinoma of breast乳房浸润性小叶状癌
5.Correlative Research of the Pathologic Features of Invasive Micropapillary Carcinoma of the Breast;乳腺浸润性微乳头状癌病理学特征的相关研究
6.Transurethral resection of high-risk multiple non-muscle invasive bladder tumor:report of 21 cases经尿道电切术治疗高危多发性非肌层浸润性膀胱癌(附21例报告)
7.Analysis of the Correlation Factor about the Predicting Recurrence and Progression in Nonmuscle Invasive Urothelial Bladder Carcinoma;预测非肌层浸润性膀胱癌复发和进展的相关因素分析
8.The treatment of non-muscle invasive bladder cancer by using intravesical instillation with mitomycin after TURBT经尿道电切联合丝裂霉素膀胱内灌注治疗非肌层浸润性膀胱癌
9.Predicting recurrence of bladder non-muscular invasive urothelial cancer using WHO histological classificationWHO分级法预测膀胱非肌层浸润性尿路上皮癌复发的价值
10.Clinical observation of differrent fiber holmium laser in the therapy of superficial bladder cancer不同光纤钬激光治疗非肌层浸润性膀胱癌的临床观察
11.Characteristic of HER-2 in Beijing inpatients with invasive breast cancer北京市住院女性浸润性乳腺癌HER-2受体状态特征分析
12.Exploration of Specific Biomarkers in Tumor Tissue Sample of the Stage Ⅱ Infiltrating Ductal Breast Cancer;乳腺浸润型导管癌（Ⅱ期）实体瘤肿瘤特异性生物标志物的初探
13.The Clinicopathologic Characteristics and Expression of HGF/c-Met Proteins in Invasive Micropapillary Carcinoma of Breast;乳腺浸润性微乳头状癌的临床病理学特征及HGF/c-Met蛋白的表达
14.The irregular mass lesion seen here is an infiltrating ductal carcinoma of breast.不规则块状病变是乳腺浸润性导管癌。
15.Intra artery infusion chemotherapy for the treatment of invasive bladder cancer髂内动脉灌注化疗治疗浸润性膀胱癌
16.Expressions of CD24 in Breast Invasive Ductal Carcinoma;CD24在乳腺浸润性导管癌中表达的研究
17.The Diagnostic Value of Infiltrated Mammo-ductal Carcinoma by Molybdenum Target X-ray钼靶CR对浸润性导管癌的诊断价值
18.The Diagnostic Experience in Image of Ninty-six Breast Infiltrating Ductal Carcinoma乳腺浸润性导管癌96例影像诊断体会
相关短句/例句
Non-special type invasive carcinoma of breast乳腺浸润性非特殊型癌
3)nonspecific invasive breast carcinoma浸润性非特殊癌
1.Background and Objective: To investigate the factors related with axillary Lymph node metastases fromnonspecific invasive breast carcinoma and to provide scientific basis for deciding conditions of breast cancer patients and giving auxiliary treatments after radical mastectomy.目的:探讨乳腺浸润性非特殊癌腋淋巴结转移的相关因素。
4)infiltrating ductal carcinoma浸润性导管癌
1.Differential proteomic analysis in stage Ⅱ breastinfiltrating ductal carcinoma tissue with negative estrogen receptorER~- Ⅱ期乳腺浸润性导管癌的差异表达蛋白质分析
2.Objective:The aim of this study was to investigate the X-ray features ofinfiltrating ductal carcinoma and to analysis its pathological basis and to rise the level of the preoperative diagnostic accuracy.目的:研究浸润性导管癌的X线表现,分析其病理学基础,以提高乳腺癌手术前的诊断水平。
3.Purpose To detect the expression of matrix metalloproteinase-26(MMP-26) in human benign and malignant breast tissues,to evaluate the relationship of MMP-26 expression ininfiltrating ductal carcinoma(IDC)with clinicopathological parameters and its potential value in tumor progression and to explore the correlation of MMP-26 with estrogen receptor(ER).方法应用免疫组化SP法,检测MMP-26蛋白在正常乳腺组织、乳腺增生症、原位癌和乳腺浸润性导管癌(IDC)中的表达,以及ER在IDC中的表达并进行评分,结果用INSTAT统计软件分析。
5)Invasive ductal carcinoma浸润性导管癌
1.Expression of Ezrin and Galectin-3 and their clinicopathological significance in breast invasive ductal carcinoma;乳腺浸润性导管癌中Ezrin、Galectin-3的表达及临床病理意义
2.Reproducibility in evaluating immunohistochemical results of HER2 expression in breast invasive ductal carcinoma;乳腺浸润性导管癌HER2免疫组化检测结果判定的重复性研究
3.Expression and clinicopathologic significance of Ki-67 in breast invasive ductal carcinoma;乳腺浸润性导管癌Ki-67表达及其临床病理学意义
6)IDC浸润性导管癌
1.Objective To study the relationship between the expression of p57KIP2 and clinicopathological characteristics in invasive duct carcinoma(IDC).目的研究p57KIP2在乳腺浸润性导管癌(invasive duct carcinoma,IDC)中的表达及与临床病理特征的关系。
2.Objective To study the expression cyclinD1,and p57KIP2in invasive duct carcinoma (IDC) and their clinical significances.目的研究cyclinD1、p57KIP2在乳腺浸润性导管癌(IDC)中的表达及意义。
3.[Background and Objective] Breast cancer is one of the most common malignant tumors in women with 75% of which exhibiting invasive ductal carcinoma (IDC) when diagnosed.乳腺癌的75%表现为浸润性导管癌,目前按病理学进程大致将其发生划分为正常乳腺上皮→增生→不典型增生→原位癌→浸润性癌→转移性癌等几个阶段,但其过程中确切分子机制至今仍不详。
延伸阅读
非特〈书〉不但。
